EUVIMEDEUVIMED entdecken
Vergleichsstudie

Outcomes Stratified by Adapted Inclusion Criteria After Transcatheter Tricuspid Edge‐to‐Edge Repair

Giulio Russo iD, Daniela Pedicino, Marianna Adamo iD, Hannes Alessandrini, Martin Andreas iD, Daniel Braun, Kim A Connelly iD, Gaetano Chiricolo, Paolo Denti iD, Rodrigo Estevez-Loureiro iD, Neil Fam, Rebecca T Hahn und 37 weitere

Catheterization and Cardiovascular Interventions · 2026

DOI: 10.1002/ccd.70763 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2026. Verfasst von Giulio Russo und 48 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedicine and Prevention, Cardiology Unit, Policlinico Tor Vergata, University of Rome, Italy. Hauptthemen laut MEDLINE: Cardiac Catheterization, Heart Valve Prosthesis Implantation, Tricuspid Valve, Tricuspid Valve Insufficiency. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Recent trials demonstrated that tricuspid transcatheter edge‐to‐edge repair (T‐TEER) is particularly effective for symptoms and quality of life improvement. However, its effect on prognosis is still unclear. Moreover, the applicability of trials inclusion/exclusion criteria has not been investigated.

Aims

The aim of the present study is to investigate the applicability of TRILUMINATE and Tri.Fr trials inclusion and exclusion criteria on real‐world patients from TRIVALVE registry, and to evaluate their effects on outcomes.

Methods

Patients undergoing T‐TEER were selected from the TRIVALVE registry and, according to inclusion and exclusion criteria, divided in four groups: TRILUMINATE eligible versus ineligible and Tri.Fr eligible versus ineligible patients. TRILUMINATE and Tri.Fr analysis were conducted separately.

Results

From a total of 664 patients of the TRIVALVE registry, 520 and 519 were included in the TRILUMINATE and Tri.Fr analysis, respectively. In particular, 240 patients (46%) met the TRILUMINATE criteria and 260 (50%) those of Tri.Fr. Baseline characteristics were significantly different between trials' eligible and ineligible patients. TRILUMINATE‐eligible patients showed significant lower mortality/rehospitalization compared to ineligible ones (12% vs. 25%, p = 0.028), as well as Tri.Fr‐eligible versus ineligible ones (15% vs. 22%, p = 0.007).

Conclusions

In patients with TR undergoing T‐TEER, inclusion and exclusion criteria of TRILUMINATE and Tri.Fr are applicable to around half of real‐world patients. Patients matching trials criteria have lower mortality/rehospitalization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiac CatheterizationHeart Valve Prosthesis ImplantationTricuspid ValveTricuspid Valve InsufficiencyPatient SelectionHumansRegistriesTreatment OutcomeFemaleTime FactorsMaleRecovery of FunctionRisk FactorsAgedAged, 80 and overRisk AssessmentHeart Valve Prosthesis

Stichwörter der Autor:innen

transcatheter edge‐to‐edge repairtranscatheter tricuspid valve interventiontrialtricuspid regurgitationtricuspid valvevalvular heart disease

Autor:innen und Institutionen

  • Department of Biomedicine and Prevention, Cardiology Unit, Policlinico Tor Vergata, University of Rome, Italy.
  • Polo Cardiovascolare, Fondazione Policlinico Universitario A Gemelli IRCSS, Rome, Italy.
  • Università Cattolica del Sacro Cuore, Rome, Italy.
  • Institute of Cardiology, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.
  • Medical Care Center Prof. Mathey, Prof. Schofer, Asklepios clinic Sankt Georg, Hamburg, Germany.
  • Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.

ORCID-Profile: Giulio Russo, Marianna Adamo, Martin Andreas, Kim A Connelly, Paolo Denti, Rodrigo Estevez-Loureiro, Joerg Hausleiter, Daniel Kalbacher, Azeem Latib, Sebastian Ludwig, Gianluca Massaro, Marco Metra, Alberto Pozzoli, Fabien Praz, Andrea Scotti, Gilbert H L Tang, Isaac Pascual, Holger Thiele, Florian Schlotter, Maurice Enriquez-Sarano

Zitieren

APA

Russo, G., Pedicino, D., Adamo, M., Alessandrini, H., Andreas, M., Braun, D., Connelly, K. A., Chiricolo, G., Denti, P., Estevez-Loureiro, R., Fam, N., Hahn, R. T., Harr, C., Hausleiter, J., Himbert, D., Kalbacher, D., Ho, E., Latib, A., Lubos, E., …, & Taramasso, M. (2026). Outcomes Stratified by Adapted Inclusion Criteria After Transcatheter Tricuspid Edge‐to‐Edge Repair. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70763

Vancouver

Russo G, Pedicino D, Adamo M, Alessandrini H, Andreas M, Braun D, et al. Outcomes Stratified by Adapted Inclusion Criteria After Transcatheter Tricuspid Edge‐to‐Edge Repair. Catheterization and Cardiovascular Interventions. 2026. doi:10.1002/ccd.70763

BibTeX
@article{Russo2026,
  author = {Russo, Giulio and Pedicino, Daniela and Adamo, Marianna and Alessandrini, Hannes and Andreas, Martin and Braun, Daniel and Connelly, Kim A and Chiricolo, Gaetano and Denti, Paolo and Estevez-Loureiro, Rodrigo and Fam, Neil and Hahn, Rebecca T and Harr, Claudia and Hausleiter, Joerg and Himbert, Dominique and Kalbacher, Daniel and Ho, Edwin and Latib, Azeem and Lubos, Edith and Ludwig, Sebastian and Massaro, Gianluca and Lurz, Philipp and Metra, Marco and Monivas, Vanessa and Nickenig, Georg and Pedrazzini, Giovanni and Pozzoli, Alberto and Praz, Fabien and Rodes-Cabau, Joseph and Besler, Christian and Rommel, Karl-Philipp and Schofer, Joachim and Scotti, Andrea and Piayda, Kerstin and Sangiorgi, Giuseppe Massimo and Sievert, Horst and Tang, Gilbert H L and Pascual, Isaac and Thiele, Holger and Schlotter, Florian and Natale, Andrea and Stephan von Bardeleben, Ralph and Webb, John and Windecker, Stephan and Leon, Martin and Enriquez-Sarano, Maurice and Maisano, Francesco and Bloechlinger, Stefan and Taramasso, Maurizio},
  title = {Outcomes Stratified by Adapted Inclusion Criteria After Transcatheter Tricuspid Edge‐to‐Edge Repair},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2026},
  doi = {10.1002/ccd.70763}
}
Kostenlos starten →